drugset / Trial / NCT01803360
Efficacy Study of Neridronate to Treat Painful Osteoarthritis of the Knee With Bone Marrow Lesions.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether neridronate is effective in the treatment of pain related to bone marrow oedema in patients with osteoarthritis of the knee.
Timeline
- Start
- 2013-03
- Primary completion
- 2013-07
- Completion
- 2013-09
Outcome
Met primary endpoint
paper the VAS decreased significantly more in the neridronate group [from 59.0 (s.d. 14.7) to 30.4 (s.d. 15.6); -48.4%; P < 0.001]. PMID 25998450 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Neridronate | Unknown | 100 mg | Intravenous |